1. Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681–96.
2. Hertzman Johansson C, Egyhazi Brage S. BRAF inhibitors in cancer therapy. Pharmacol Ther. 2014;142(2):176–82.
3. National Comprehensive Cancer Network®. NCCN clinical practice guideline in oncology (NCCN Guidelines®)—melanoma (version 3.2018). 2018. https://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf . Accessed 20 Jul 2018.
4. US FDA. Braftovi™ (encorafenib) capsules: US prescribing information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210496lbl.pdf . Accessed 20 Jul 2018.
5. US FDA. Mektovi® (binimetinib) tablets: US prescribing information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210498lbl.pdf . Accessed 20 Jul 2018.